APA (7th ed.) Citation

Richardson, T., Mai, E. K., Menis, E., Benner, A., Tichy, D., Miah, K., . . . Scheid, C. (2026). Prognostic impact of the Hevylite Assay in patients with IgG or IgA multiple myeloma treated within the GMMG-MM5 trial. European journal of haematology, 116(3), . https://doi.org/10.1111/ejh.70061

Chicago Style (17th ed.) Citation

Richardson, Tim, et al. "Prognostic Impact of the Hevylite Assay in Patients with IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial." European Journal of Haematology 116, no. 3 (2026). https://doi.org/10.1111/ejh.70061.

MLA (9th ed.) Citation

Richardson, Tim, et al. "Prognostic Impact of the Hevylite Assay in Patients with IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial." European Journal of Haematology, vol. 116, no. 3, 2026, https://doi.org/10.1111/ejh.70061.